Collins Stewart Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Hold; Uncomfortable with the Numerous Overhangs Within Each Business
Tweet Send to a Friend
Collins Stewart downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) to Hold.
Collins analyst says, "We arrive at a hypothetical $33 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Collins analyst says, "We arrive at a hypothetical $33 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
